Mobile Cardiac Telemetry Systems Market Report 2026

Mobile Cardiac Telemetry Systems Market Overview

• Mobile Cardiac Telemetry Systems market size has reached to $1.06 billion in 2025 • Expected to grow to $1.7 billion in 2030 at a compound annual growth rate (CAGR) of 9.9% • Growth Driver: Rising Cardiovascular Disease Incidence Drives Growth In Mobile Cardiac Telemetry Systems Market • Market Trend: Innovative Real-Time Monitoring Enhances Diagnostic Speed And Clinical Intervention In Cardiac Care • North America was the largest region in 2025.

What Is Covered Under Mobile Cardiac Telemetry Systems Market?

Mobile cardiac telemetry systems are advanced cardiac monitoring devices used to detect and record abnormal heart rhythms in real-time. They continuously monitor a patient's heart activity and automatically transmit data to a central monitoring center. This allows for immediate analysis and timely intervention by healthcare professionals. MCT systems are typically used for diagnosing and managing arrhythmias and other cardiac conditions. The main product types of mobile cardiac telemetry systems are multiple lead mobile cardiac telemetry systems and mobile cardiac telemetry patches. Multiple lead mobile cardiac telemetry systems use several electrodes placed on a patient's body to monitor heart activity continuously. The diseases are cardiovascular diseases, angina pectoris, atherosclerosis, heart failure, and others, and they are used by various end-users such as hospitals, cardiac centers, home care settings, and others.

What Is The Mobile Cardiac Telemetry Systems Market Growth Forecast?

The mobile cardiac telemetry systems market size is expected to see strong growth in the next few years. It will grow to $1.7 billion in 2030 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to growing adoption of remote patient monitoring, increasing demand for early cardiac event detection, expansion of home-based healthcare services, rising focus on continuous real-time cardiac data, improving access to digital cardiac care solutions. Major trends in the forecast period include rising adoption of continuous remote cardiac monitoring, growing shift toward ambulatory and home-based cardiac care, increasing use of patch-based cardiac telemetry devices, expansion of real-time arrhythmia detection and alert systems, growing demand for long-term cardiac rhythm monitoring.

Global Mobile Cardiac Telemetry Systems Market Segmentation

1) By Product Type: Multiple Lead Mobile Cardiac Telemetry Systems, Mobile Cardiac Telemetry Patch 2) By Monitoring & Service Model: Continuous Real-Time Monitoring, Intermittent or Event-Triggered Monitoring, Prescription-Based Remote Patient Monitoring Platforms, Managed or Outsourced Monitoring Services, Device-as-a-Service or Subscription-Based Models, Hybrid Monitoring Models 3) By End-Use: Hospitals, Cardiac Centers, Home Care Settings, Other End-Uses Subsegments: 1) By Multiple Lead Mobile Cardiac Telemetry Systems: Wired Multiple Lead Systems, Wireless Multiple Lead Systems 2) By Mobile Cardiac Telemetry Patch: Adhesive Patches, Disposable Patches

What Is The Driver Of The Mobile Cardiac Telemetry Systems Market?

The growing incidence of cardiovascular disease is expected to propel the growth of the mobile cardiac telemetry systems market going forward. Cardiovascular diseases are a group of diseases that affect the heart and blood vessels, including conditions such as coronary artery disease, heart failure, arrhythmias, and hypertension, which can lead to serious health complications like heart attacks, strokes, and other cardiovascular events. The rate of cardiovascular disease is rising due to the increasing prevalence of risk factors such as sedentary lifestyles, poor diets, obesity, and aging populations. Mobile cardiac telemetry systems enable continuous, real-time monitoring and early detection of cardiac arrhythmias in patients with cardiovascular disease. For instance, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000 in 2024, up 4.0% from 224.4 per 100,000 in 2023. Therefore, the growing incidence of cardiovascular disease is driving the growth of the mobile cardiac telemetry systems industry.

Key Players In The Global Mobile Cardiac Telemetry Systems Market

Major companies operating in the mobile cardiac telemetry systems market are Medtronic PLC, Philips Healthcare, Boston Scientific Corporation, iRhythm Technologies Inc., Biotricity Inc., Zoll Medical Corporation, Spacelabs Healthcare, Infobionic Inc., Medicomp Inc., ScottCare Corporation, Medicalgorithmics S.A., Ambucor Health Solutions Inc., Telerhythmics LLC, Vitaphone GmbH, Card Guard, Heart Test Laboratories Inc., Reactdx, Nuvant Health, Bittium Corporation, Fukuda Denshi Co Ltd, GE HealthCare, Mindray Medical International

Global Mobile Cardiac Telemetry Systems Market Trends and Insights

Major companies operating in the mobile cardiac telemetry systems market are developing innovative solutions such as advanced wearable ECG devices to enhance real-time cardiac data accuracy and remote patient management. ECG devices are medical instruments that record the electrical activity of the heart to detect and monitor heart conditions. For instance, in October 2023, Biotricity Inc., a US-based medical diagnostics company, launched BioTresPro, a next-generation three-channel wearable cardiac monitoring device designed to support uninterrupted real-time telemetry. The system includes integrated cellular backup for seamless data transmission, continuous multi-lead ECG acquisition for improved signal quality, and enhanced remote connectivity features that ensure uninterrupted monitoring even in low-coverage areas. These capabilities allow clinicians to detect critical cardiac events sooner and make faster care decisions for patients under ambulatory monitoring.

What Are Latest Mergers And Acquisitions In The Mobile Cardiac Telemetry Systems Market?

In May 2024, WearLinq, Inc., Us-based healthcare technology company, acquired AMI Cardiac Monitoring LLC for $6.7 million. amount, with this acquisition of WearLinq aims to significantly enhance WearLinq's capacity to provide clinical services and improve cardiac diagnostics across the United States. AMI Cardiac Monitoring, LLC is a US -basedhealthcare company specializing in providing remote cardiac monitoring services.

Regional Outlook

North America was the largest region in the mobile cardiac telemetry systems market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Mobile Cardiac Telemetry Systems Market?

The mobile cardiac telemetry systems market consists of sales of wearable sensors, transmitter devices, and data transmission units. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.